Healthy
Conditions
Interventions
investigational material(s)
Generic name etc : Treprostinil
INN of investigational material :
Therapeutic category code : 219 Other cardiovascular agents
Dosage and Administration for Investigational
Sponsors
Eli Lilly Japan K.K.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion Criteria: Overtly healthy Japanese Body mass index (BMI) 18.5 - 25 kilograms per square meter (kg/m2) Fasting plasma glucose >=71 milligrams per deciliter (mg/dL) (3.9 millimoles per liter [mmol/L]) and <108 mg/dL (6.0 mmol/L) (Part B only) Have normal blood pressure, pulse rate, electrocardiogram (ECG), blood and urine laboratory test results that are acceptable for the study Exclusion Criteria: Are currently enrolled in a clinical trial involving an investigational product or any other type of medical research judged not to be scientifically or medically compatible with this study Have participated in a clinical trial involving an investigational product within the 30 days before study entry Have previously completed or withdrawn from this study or any other study investigating treprostinil or LY900014, and have previously received the investigational product Have or used to have health problems or laboratory test results or ECG readings that, in the opinion of the doctor, could make it unsafe to participate, or could interfere with understanding the results of the study
Exclusion criteria
Exclusion criteria:
Outcome results
None listed